<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Bariatric operations: Late complications with subacute presentations
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Bariatric operations: Late complications with subacute presentations
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Bariatric operations: Late complications with subacute presentations
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            James C Ellsmere, MD, MSc, FRCSC
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Daniel Jones, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Wenliang Chen, MD, PhD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jul 18, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The number of bariatric surgical operations performed in the United States has steadily increased. It is estimated that 199,000 weight-loss surgeries were performed in 2020 [
         <a href="#rid1">
          1
         </a>
         ]. Of those, 59 percent were sleeve gastrectomy, 21 percent were gastric bypass, 1.2 percent were adjustable gastric band, and 1.8 percent were biliopancreatic diversion with duodenal switch. The remaining 11 percent were revisional procedures.
        </p>
        <p>
         Complications following the surgical treatment of severe obesity vary based upon the procedure performed and can be as high as 40 percent [
         <a href="#rid2">
          2-4
         </a>
         ]. Due to the high surgical volume, improving the safety of these operations has become a high priority.
        </p>
        <p>
         This topic will review the major late complications of bariatric surgery, defined as occurring after 30 days, that present subacutely or chronically. Early complications and late complications that present acutely are discussed in other topics:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/87686.html" rel="external">
          "Bariatric operations: Early (fewer than 30 days) morbidity and mortality"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/140689.html" rel="external">
          "Bariatric operations: Late complications with acute presentations"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Nutritional complications are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/587.html" rel="external">
          "Bariatric surgery: Postoperative nutritional management"
         </a>
         .)
        </p>
        <p>
         A description of bariatric procedures, indications and preoperative management, medical outcomes, and individual bariatric operations can be found in other topics:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/88536.html" rel="external">
          "Bariatric procedures for the management of severe obesity: Descriptions"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/586.html" rel="external">
          "Bariatric surgery for management of obesity: Indications and preoperative preparation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/90469.html" rel="external">
          "Outcomes of bariatric surgery"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/109434.html" rel="external">
          "Laparoscopic Roux-en-Y gastric bypass"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/109435.html" rel="external">
          "Laparoscopic sleeve gastrectomy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3369779438">
         <span class="h1">
          COMPLICATIONS COMMON TO ALL PROCEDURES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Late complications that can occur after all bariatric procedures include cholelithiasis, incisional hernias, and change in bowel habits.
        </p>
        <p class="headingAnchor" id="H3048558770">
         <span class="h2">
          Cholelithiasis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Gallstones can develop after bariatric surgery due to an increased biliary cholesterol concentration following rapid weight loss, gallbladder hypomotility secondary to vagal nerve resection and a decreased cholecystokinin secretion, an increased secretion of calcium and biliary mucin, and a disturbed enterohepatic circulation of biliary salts [
         <a href="#rid5">
          5,6
         </a>
         ]. After a mean follow-up of 29 months after a variety of bariatric operations, cholelithiasis develops in as many as 20.7 percent of patients, and 8.2 percent of patients become symptomatic, which is three times higher than in the general population [
         <a href="#rid7">
          7
         </a>
         ]. Gallstones can develop after all bariatric operations [
         <a href="#rid6">
          6
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/662.html" rel="external">
          "Gallstones: Epidemiology, risk factors and prevention"
         </a>
         .)
        </p>
        <p>
         The decision to perform a cholecystectomy at the time of bariatric surgery is controversial. Some surgeons recommend performing cholecystectomy at the time of bariatric surgery if a patient has symptomatic gallstones preoperatively. The surgical opinion about asymptomatic gallstones is more divided, as studies have associated a greater number of complications (odds ratio 1.2, 95% CI 1.1-1.3), albeit not severe ones, with simultaneous cholecystectomy at the time of bariatric surgery [
         <a href="#rid7">
          7,8
         </a>
         ].
        </p>
        <p>
         The frequency of cholelithiasis can be reduced from 25 to 7 percent with a six-month course of
         <a class="drug drug_general" data-topicid="10033" href="/z/d/drug information/10033.html" rel="external">
          ursodeoxycholic acid
         </a>
         (UDCA; ursodiol, a synthetic bile salt) at 600 mg/day given prophylactically after weight-loss surgery [
         <a href="#rid9">
          9
         </a>
         ]. A meta-analysis of 11 randomized trials found that UDCA significantly reduces the risk of both asymptomatic (odds ratio 0.29) and symptomatic gallstones (odds ratio 0.25) and the need for cholecystectomy (odds ratio 0.33) after bariatric surgery [
         <a href="#rid10">
          10
         </a>
         ]. The adoption of a six-month course of prophylactic UDCA has been variable despite the evidence and society guidelines [
         <a href="#rid11">
          11
         </a>
         ]. Some experts adopt it after Roux-en-Y gastric bypass (RYGB) but not sleeve gastrectomy (SG) because of the anatomical difficulties associated with the former if endoscopic treatment of gallstone disease is required.
        </p>
        <p>
         Patients who develop choledocholithiasis (stones in the common bile duct) after gastric bypass can be challenging to treat with endoscopic retrograde cholangiopancreatography (ERCP) due to the Roux-en-Y configuration  (
         <a class="graphic graphic_figure graphicRef52350" href="/z/d/graphic/52350.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid12">
          12
         </a>
         ]. As a result, surgery or transhepatic percutaneous access may be required. This is discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/15864.html" rel="external">
          "ERCP in patients with Roux-en-Y anatomy"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H810134165">
         <span class="h2">
          Ventral incisional hernia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Severe obesity is associated with increased intra-abdominal pressure, and thus, a high risk of hernia development after any abdominal surgery. In a study of over 2161 patients undergoing bariatric surgery, ventral incisional hernias occurred in 2.4 percent at a follow-up of 28±25 months [
         <a href="#rid13">
          13
         </a>
         ]. Patients are 10 times more likely to develop a hernia after open than laparoscopic surgery. Other risk factors include malnutrition, prior abdominal surgery, and a body mass index greater than 60 kg/m
         <sup>
          2
         </sup>
         .
        </p>
        <p>
         Incisional hernias present with an enlarging bulge, pain, or obstructive symptoms. Many surgeons postpone a formal repair until significant weight loss occurs (&gt;1 year). Indications for early surgical repair include significant pain, bowel obstruction, and rapid enlargement of the hernia. (See
         <a class="medical medical_review" href="/z/d/html/117731.html" rel="external">
          "Clinical features, diagnosis, and prevention of incisional hernias"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/96301.html" rel="external">
          "Management of ventral hernias"
         </a>
         .)
        </p>
        <p>
         The management of an existing ventral hernia in patients seeking bariatric surgery should be individualized [
         <a href="#rid14">
          14,15
         </a>
         ]. There is some evidence that hernia repair and bariatric surgery may be performed concomitantly, although there are limited data addressing the safety of synthetic mesh placement [
         <a href="#rid16">
          16
         </a>
         ]. For larger hernias not amenable to laparoscopic repair, most surgeons would delay hernia repair/abdominal wall reconstruction until after bariatric surgery and expected weight loss [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1619727797">
         <span class="h2">
          Change in bowel habits
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients can expect some change in bowel habits after bariatric surgery, although significant alterations can negatively impact quality of life. In general, loose stool and diarrhea are more common after biliopancreatic diversion (BPD) and RYGB, while constipation is more common after restrictive procedures such as adjustable gastric banding [
         <a href="#rid18">
          18,19
         </a>
         ]. The outcome of SG is variable [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
         In a study of 208 patients, BPD patients reported a higher frequency of bowel movements, more trouble with flatus and urgency, and increased need for keeping a diet compared with RYGB patients. However, general quality of life was improved over baseline after both procedures [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p>
         Changes in bowel habits after bariatric surgery may be transient. In another study, 573 patients who underwent all types of bariatric surgery reported worsened bowel function at two weeks after surgery. However, by three months, the reported bowel function was already better than the baseline, and the improvement was sustained to two years [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1509956487">
         <span class="h1">
          PROCEDURE-SPECIFIC COMPLICATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H27">
         <span class="h2">
          Roux-en-Y gastric bypass
         </span>
         <span class="headingEndMark">
          —
         </span>
         Roux-en-Y gastric bypass (RYGB) involves the creation of a small gastric pouch and an anastomosis to a Roux limb of jejunum that bypasses 75 to 150 cm of small bowel, thereby restricting food and limiting absorption  (
         <a class="graphic graphic_figure graphicRef52350" href="/z/d/graphic/52350.html" rel="external">
          figure 1
         </a>
         ). This procedure is the second most common weight loss procedure performed after sleeve gastrectomy. The complications of RYGB are diverse and vary based upon the specific technique. (See
         <a class="medical medical_review" href="/z/d/html/109434.html" rel="external">
          "Laparoscopic Roux-en-Y gastric bypass"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H35">
         <span class="h3">
          Dumping syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Dumping syndrome is a common complication of esophageal or gastric surgery, including bariatric surgery. The surgically altered anatomy delivers undigested food rapidly into the intestine, thereby triggering a constellation of gastrointestinal and vasomotor symptoms [
         <a href="#rid23">
          23
         </a>
         ].
        </p>
        <p>
         In a Danish survey of 1429 patients who underwent gastric bypass, 9.4 and 6.6 percent reported experiencing moderate-to-severe symptoms indicative of early dumping and hypoglycemia, respectively [
         <a href="#rid24">
          24
         </a>
         ]. In that cohort, the total prevalence of one or both types of symptoms was 12.6 percent (95% CI 10.9-14.4). Patients who were younger than 35 years of age or had a body mass index (BMI) &lt;25 kg/m
         <sup>
          2
         </sup>
         were more likely to be symptomatic than those who were older or had a higher BMI. Dumping may contribute to weight loss in part by causing patients to modify their eating habits. (See
         <a class="medical medical_review" href="/z/d/html/89634.html" rel="external">
          "Postgastrectomy complications", section on 'Dumping syndrome'
         </a>
         .)
        </p>
        <p>
         There are two types of dumping syndrome, early and late [
         <a href="#rid23">
          23,25
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1385450998">
         <span class="h4">
          Early dumping syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Early dumping syndrome has a rapid onset, usually within one hour of eating. It is the result of rapid emptying of food into the small bowel. Due to the hyperosmolality of the food, rapid fluid shifts from the plasma into the bowel occur, resulting in hypotension and a sympathetic nervous system response. Patients often present with gastrointestinal symptoms (abdominal pain, bloating, borborygmi, nausea, and diarrhea) and vasomotor symptoms (flushing; palpitations; perspiration; tachycardia; hypotension; fatigue; a desire to lie down; and, rarely, syncope) [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p>
         Patients should avoid foods high in simple sugar content and replace them with a diet consisting of high-fiber, complex carbohydrate, and protein-rich foods. Behavioral modification, such as small, frequent meals, slow eating, chewing well, and separating solid from liquid intake by 30 minutes, is also advocated. Usually, early dumping is self-limiting and resolves within 7 to 12 weeks [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p>
         Dietary supplements that increase the viscosity of food (such as guar gum, pectin, and glucomannan) or pharmacologic agents (such as
         <a class="drug drug_general" data-topicid="9219" href="/z/d/drug information/9219.html" rel="external">
          acarbose
         </a>
         ) are a good second-line treatment for symptoms of dumping syndrome after dietary modification [
         <a href="#rid23">
          23
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1562749992">
         <span class="h4">
          Postprandial hyperinsulinemic hypoglycemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Previously referred to as "late dumping syndrome," postprandial hyperinsulinemic hypoglycemia (PHH) is a rare complication of bariatric surgery. It occurs in 0.1 to 0.3 percent of patients, most commonly after gastric bypass. Symptoms of PHH, including dizziness, fatigue, diaphoresis, and weakness, usually occur one to three hours after ingesting a carbohydrate-rich meal, typically months to years after surgery, and are associated with documented hypoglycemia [
         <a href="#rid28">
          28
         </a>
         ]. The pathophysiology of PHH is not fully understood but likely includes alterations in multiple hormonal and glycemic patterns (eg, increase in incretin levels). (See
         <a class="medical medical_review" href="/z/d/html/1798.html" rel="external">
          "Hypoglycemia in adults without diabetes mellitus: Determining the etiology"
         </a>
         .)
        </p>
        <p>
         Most patients with PHH can be managed with the same dietary modification suggested above for early dumping syndrome. Patients who are refractory to dietary modification can be treated with medications (eg,
         <a class="drug drug_general" data-topicid="9700" href="/z/d/drug information/9700.html" rel="external">
          nifedipine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9219" href="/z/d/drug information/9219.html" rel="external">
          acarbose
         </a>
         ,
         <a class="drug drug_general" data-topicid="9346" href="/z/d/drug information/9346.html" rel="external">
          diazoxide
         </a>
         , or
         <a class="drug drug_general" data-topicid="9714" href="/z/d/drug information/9714.html" rel="external">
          octreotide
         </a>
         ), gastrostomy tube feeding into the remnant stomach, or revisional bariatric surgery. Pancreatic resection has unproven benefit and should not be performed for PHH. (See
         <a class="medical medical_review" href="/z/d/html/1769.html" rel="external">
          "Evaluation of postprandial symptoms of hypoglycemia in adults without diabetes"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H36">
         <span class="h3">
          Metabolic derangements
         </span>
         <span class="headingEndMark">
          —
         </span>
         Metabolic and nutritional derangements are common in patients with severe obesity and can be exacerbated following bariatric surgery, making postoperative lifelong compliance with appropriate dietary choices and vitamin supplementation imperative. Decreased oral intake, as well as altered absorption of food from the stomach and small bowel, reduces absorption of various micronutrients, particularly iron, calcium, vitamin B12, thiamine, and folate.
        </p>
        <p>
         Metabolic derangements that are most common after RYGB are presented here. Nutritional deficiencies are discussed in a separate topic. (See
         <a class="medical medical_review" href="/z/d/html/587.html" rel="external">
          "Bariatric surgery: Postoperative nutritional management", section on 'Micronutrient management'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14879976">
         <span class="h4">
          Nephrolithiasis and renal failure
         </span>
         <span class="headingEndMark">
          —
         </span>
         RYGB has been linked to metabolic changes that can alter urine chemistry profiles, resulting in higher calcium oxalate supersaturation and urine oxalate, lower citrate, and lower volume. Consequently, patients have a higher risk of developing nephrolithiasis after RYGB (pooled relative risk 1.79, 95% CI 1.54-2.10) [
         <a href="#rid29">
          29
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7375.html" rel="external">
          "Kidney stones in adults: Epidemiology and risk factors"
         </a>
         .)
        </p>
        <p>
         While uncommon, increased absorption of calcium oxalate can also lead to deposition in the renal parenchyma, resulting in oxalate nephropathy and renal failure [
         <a href="#rid30">
          30
         </a>
         ]. A retrospective review of 11 patients with oxalate nephropathy found that all were hypertensive, and nine had diabetes before the procedure [
         <a href="#rid31">
          31
         </a>
         ]. Renal biopsies revealed diffuse tubular degenerative changes, abundant tubular calcium oxalate deposits, and varying degrees of tubulointerstitial scarring. Effective medical therapy is lacking [
         <a href="#rid32">
          32
         </a>
         ], although anecdotal reports have shown that reversing the gastric bypass may help [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1030302811">
         <span class="h4">
          Metabolic bone changes and secondary hyperparathyroidism
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vitamin D deficiency and secondary hyperparathyroidism already exists in 60 to 84 percent and 42 to 49 percent of patients seeking bariatric surgery, respectively [
         <a href="#rid34">
          34,35
         </a>
         ]. RYGB further exacerbates calcium deficiency and reduces bone mineral density by reducing dietary calcium intake, calcium absorption (from bypassing the proximal small intestine and reducing gastric acidity), and reducing mechanical loading (from weight loss) [
         <a href="#rid36">
          36-39
         </a>
         ]. Reducing the bone mineral density of the skeletal system can increase the risk of fracture [
         <a href="#rid40">
          40
         </a>
         ]. The increased risk of fractures varies from 25 percent to 2.6-fold, depending on studies [
         <a href="#rid41">
          41-44
         </a>
         ]. Treatment options include calcium/vitamin D supplementation and exercise [
         <a href="#rid45">
          45
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/587.html" rel="external">
          "Bariatric surgery: Postoperative nutritional management", section on 'Vitamin D'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/587.html" rel="external">
          "Bariatric surgery: Postoperative nutritional management", section on 'Calcium'
         </a>
         .)
        </p>
        <p>
         The prevalence of secondary hyperparathyroidism (SHPT) is high in patients with obesity before bariatric surgery, which is related to vitamin D deficiency. The prevalence of SHPT increased continually along with the time after bariatric surgery, especially in patients receiving single anastomosis gastric bypass, followed by RYGB [
         <a href="#rid46">
          46
         </a>
         ]. A meta-analysis of nine studies found that the risk of SHPT after RYGB markedly increased after two years of follow-up (odds ratio 6.06, 95% CI 3.39-10.85) [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1384524256">
         <span class="h4">
          Hyperammonemic encephalopathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hyperammonemic encephalopathy has been reported in case reports of patients who are failing to thrive after complicated gastrointestinal surgeries that can include RYGB [
         <a href="#rid48">
          48
         </a>
         ]. The underlying etiologies are incompletely understood but include both genetic (eg, proximal urea cycle disorders) and nongenetic causes (eg, splenorenal shunt). The typical clinical features include hypoalbuminemia, hypoglycemia, low plasma zinc level, and other nutritional deficiencies [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p>
         The key to diagnosis is the early assessment of plasma ammonia levels in such patients with normal hepatic function but characteristic symptoms of encephalopathy [
         <a href="#rid50">
          50
         </a>
         ]. Once hyperammonemic encephalopathy is diagnosed, it can be treated with supportive and medical care to reduce ammonia levels. (See
         <a class="medical medical_review" href="/z/d/html/1255.html" rel="external">
          "Hepatic encephalopathy in adults: Treatment"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1017659300">
         <span class="h3">
          Short bowel syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         RYGB and other bariatric procedures can be complicated by short bowel syndrome (SBS) that results from massive small bowel resections for internal hernias or bowel obstruction from adhesions [
         <a href="#rid51">
          51
         </a>
         ]. In a retrospective review of 265 patients, 11 (4 percent) developed SBS following bariatric surgery, of which nine had prior primary or revisional RYGB [
         <a href="#rid52">
          52
         </a>
         ].
        </p>
        <p>
         Initial treatment consists of supportive measures such as total
         <a class="drug drug_general" data-topicid="10307" href="/z/d/drug information/10307.html" rel="external">
          parenteral nutrition
         </a>
         [
         <a href="#rid53">
          53
         </a>
         ]; surgical options are lengthening of the common channel, enteral nutrition via gastrostomy into the gastric remnant, and restitution of normal anatomy if still possible [
         <a href="#rid54">
          54
         </a>
         ]. In some cases, this complication may require intestinal transplantation [
         <a href="#rid55">
          55
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4770.html" rel="external">
          "Pathophysiology of short bowel syndrome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2870488029">
         <span class="h3">
          Gastrogastric fistula
         </span>
         <span class="headingEndMark">
          —
         </span>
         After RYGB, a gastrogastric fistula (GGF) is a channel that can develop between the gastric pouch and the excluded stomach remnant, allowing ingested food to enter the bypassed foregut (stomach and duodenum). GGF occurs in approximately 1 to 2 percent of patients after RYGB and most commonly causes marginal ulcers or weight regain [
         <a href="#rid56">
          56
         </a>
         ].
        </p>
        <p>
         Historically, gastric bypass surgeons stapled the stomach without completely dividing the gastric remnant from the pouch. The gastric pouch and gastric remnant stapled in continuity were associated with a 49 percent rate of GGF [
         <a href="#rid57">
          57
         </a>
         ]. The introduction of complete transection of these two segments has decreased the rate of GGF to 0 to 3 percent  (
         <a class="graphic graphic_figure graphicRef79256" href="/z/d/graphic/79256.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid56">
          56,58
         </a>
         ].
        </p>
        <p>
         When persistent marginal ulcers or significant weight regain are seen in a postgastric-bypass patient, particularly in the setting of recurrent or new-onset gastroesophageal reflux symptoms, an upper gastrointestinal series or a computed tomography (CT) scan with oral contrast should be performed to exclude a GGF as a cause. Alternatively, GGF can be diagnosed on flexible upper endoscopy [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p>
         Patients diagnosed with a GGF who also have either significant weight regain or persistent symptoms from marginal ulcers (eg, abdominal pain, stomal stenosis, or gastrointestinal bleeding) are candidates for repair of the GGF. Endoscopic techniques, including clipping, suturing, and stenting, have been used to treat GGF, but results are varied at best and recurrence rates are high [
         <a href="#rid59">
          59,60
         </a>
         ].
        </p>
        <p>
         We suggest surgical revision for patients with persistent pain, bleeding, or stenosis from a GGF. In preparation for dividing the GGF, the gastric pouch should be fully mobilized, and the path of the Roux limb should be outlined with an orogastric tube or endoscope. The GGF can be resected by stapling, in which case one must staple inside the previous staple line to avoid creating a blind pouch. Alternatively, the gastric remnant can be opened to allow the fistula to be accessed from the distal side. In some cases, either a redo gastrojejunostomy or a remnant gastrectomy may be required [
         <a href="#rid61">
          61
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H39">
         <span class="h3">
          Failure to lose weight and weight regain
         </span>
         <span class="headingEndMark">
          —
         </span>
         Failure to lose weight following RYGB is rare and is often due to maladaptive eating patterns during the early postoperative period. By contrast, significant late weight regain occurs in up to 20 percent of patients, especially those with BMI &gt;50 kg/m
         <sup>
          2
         </sup>
         at the time of the initial operation. It is often due to progressive noncompliant eating and other behavioral habits [
         <a href="#rid62">
          62,63
         </a>
         ], development of a functional GGF, gradual enlargement of the gastric pouch, or dilatation of the gastrojejunal anastomosis.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A GGF can cause weight regain by allowing food passage into the remnant stomach, thereby decreasing the restrictive effect of RYGB. The diagnosis and treatment of GGFs has been discussed above. (See
         <a class="local">
          'Gastrogastric fistula'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dilatation of the gastric pouch or the gastrojejunal anastomosis may be responsible for weight gain in other patients. The stretched pouch and/or the outlet are thought to arise from repeated overdistension due to excessive food intake. These patients usually do not benefit from the high-risk revisional surgery. However, less invasive endoscopic procedures aimed at suture reduction of the pouch size or tightening of the stoma may be successful [
         <a href="#rid64">
          64,65
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2655.html" rel="external">
          "Gastrointestinal endoscopy in patients who have undergone bariatric surgery", section on 'Stoma/pouch enlargement'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3467833116">
         <span class="h3">
          Candy cane Roux syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Candy cane Roux syndrome in patients who have undergone RYGB refers to an excessively long blind afferent Roux limb at the gastrojejunostomy causing postprandial pain often relieved by vomiting. It is believed that the blind afferent limb ("candy cane") acts as an obstructed loop when filled with food (often preferentially), and the distention of the loop causes pain until the food either spills into the Roux limb or is vomited back out  (
         <a class="graphic graphic_figure graphicRef113461" href="/z/d/graphic/113461.html" rel="external">
          figure 3
         </a>
         ) [
         <a href="#rid66">
          66
         </a>
         ].
        </p>
        <p>
         Patients have been reported presenting as early as three months and as late as 11 years after their initial RYGB, typically with symptoms of postprandial epigastric pain, nausea, vomiting, and reflux or food regurgitation [
         <a href="#rid67">
          67
         </a>
         ]. The diagnosis is confirmed by upper gastrointestinal contrast studies or endoscopy. On upper gastrointestinal series, the afferent limb fills before contrast spills into the Roux limb. On upper endoscopy, the afferent limb is usually the most direct outlet of the gastrojejunostomy [
         <a href="#rid66">
          66
         </a>
         ].
        </p>
        <p>
         The treatment is revisional bariatric surgery, most commonly laparoscopic resection of the afferent limb [
         <a href="#rid68">
          68
         </a>
         ], which ranged in length from 3 to 22 cm in one study (mean of 7.6 cm) [
         <a href="#rid66">
          66
         </a>
         ]. Symptoms resolve after revision surgery in most patients. Surgeons should minimize the length of the blind afferent loop left at the time of initial RYGB to prevent candy cane Roux syndrome.
        </p>
        <p class="headingAnchor" id="H3209516552">
         <span class="h2">
          Sleeve gastrectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Laparoscopic sleeve gastrectomy (SG) is a restrictive procedure initially developed as part of a staged approach to an RYGB for high-risk patients with class III obesity, but now typically performed as a standalone operation with good weight loss and resolution of obesity-related comorbidities. In 2013, SG surpassed RYGB as the most performed weight loss surgery in the United States [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         SG involves creating a "sleeve" of stomach over a bougie and removes a large portion of the greater curvature of the stomach, leaving a small tube along the lesser curvature  (
         <a class="graphic graphic_figure graphicRef54612" href="/z/d/graphic/54612.html" rel="external">
          figure 4
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/109435.html" rel="external">
          "Laparoscopic sleeve gastrectomy"
         </a>
         .)
        </p>
        <p>
         Significant advantages of SG include low complication (3 to 24 percent) and mortality (0.39 percent) rates, the ease of performing the procedure, preservation of the pylorus, maintenance of physiological food passage, and avoidance of foreign material [
         <a href="#rid69">
          69
         </a>
         ]. In a database study of over 38,000 patients, patients undergoing SG had fewer reinterventions (9.9 versus 15.6 percent) and complications (6.6 versus 9.6 percent) than patients undergoing RYGB in the first two years. At or after two years, revisions were slightly more common with SG than RYGB (0.6 versus 0.4 percent), primarily because of the higher incidence of gastroesophageal reflux disease (GERD) with SG [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p>
         The most common early (&lt;30 days) complications of SG, including bleeding, narrowing or stenosis of the stoma, and leaks, are discussed in another topic. (See
         <a class="medical medical_review" href="/z/d/html/87686.html" rel="external">
          "Bariatric operations: Early (fewer than 30 days) morbidity and mortality", section on 'Gastrointestinal leak'
         </a>
         .)
        </p>
        <p>
         Late (&gt;30 days) complications of SG include GERD and Barrett esophagus.
        </p>
        <p class="headingAnchor" id="H1667744432">
         <span class="h3">
          Acid reflux or Barrett esophagus
         </span>
         <span class="headingEndMark">
          —
         </span>
         GERD is common among the population with obesity and may improve after bariatric surgery because of weight loss [
         <a href="#rid71">
          71
         </a>
         ]. However, compared with RYGB, patients are more likely to develop de novo GERD after SG.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A 2020 systematic review and meta-analysis of 46 studies found that 19 percent of patients had worsening reflux, and 23 percent developed de novo reflux after SG [
         <a href="#rid72">
          72
         </a>
         ]. Additionally, 28 and 8 percent developed esophagitis and Barrett esophagus over the long term. Four percent of all patients required conversion to RYGB for severe reflux.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A 2021 systematic review and meta-analysis of 10 studies reported an 11.6 percent (95% CI 8.1-16.4) prevalence of Barrett esophagus after SG over 6 months to 10 years follow-up [
         <a href="#rid73">
          73
         </a>
         ]. Interestingly, the prevalence of Barrett esophagus did not correlate with that of GERD.
        </p>
        <p>
        </p>
        <p>
         GERD after SG presents with classic symptoms such as burning pain, heartburn, and regurgitation  (
         <a class="graphic graphic_diagnosticimage graphicRef91157" href="/z/d/graphic/91157.html" rel="external">
          image 1
         </a>
         ). It can occur as an early or late complication. The first-line treatment is antireflux medical therapy. GERD unresponsive to antireflux medical therapy with no clear anatomic abnormalities, such as stoma stenosis or a hiatal hernia, can be effectively treated by conversion to RYGB [
         <a href="#rid74">
          74,75
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2258.html" rel="external">
          "Medical management of gastroesophageal reflux disease in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1001860915">
         <span class="h2">
          Biliopancreatic diversion and duodenal switch
         </span>
         <span class="headingEndMark">
          —
         </span>
         Biliopancreatic diversion (BPD) is a malabsorptive procedure that relies on limiting absorption of fats and starches to a relatively short segment of small intestine as well as decreasing the gastric reservoir size  (
         <a class="graphic graphic_figure graphicRef67432" href="/z/d/graphic/67432.html" rel="external">
          figure 5
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/88536.html" rel="external">
          "Bariatric procedures for the management of severe obesity: Descriptions", section on 'Biliopancreatic diversion with duodenal switch'
         </a>
         .)
        </p>
        <p>
         BPD differs from jejunoileal bypass in that no intestinal limb is excluded from flow, thus avoiding creation of a blind loop (see
         <a class="local">
          'Jejunoileal bypass'
         </a>
         below). Excellent weight loss results with morbidity and mortality rates comparable to RYGB have been described by the few centers that perform BPD along with its duodenal switch variant (BPD-DS)  (
         <a class="graphic graphic_figure graphicRef54159" href="/z/d/graphic/54159.html" rel="external">
          figure 6
         </a>
         ) [
         <a href="#rid76">
          76,77
         </a>
         ].
        </p>
        <p>
         BPD-DS has not become widespread because of the technical complexity of the procedure, with historically high surgical morbidity and mortality rates and concerns regarding the long-term nutritional outcomes [
         <a href="#rid78">
          78
         </a>
         ], including significant protein-calorie malnutrition, anemia, metabolic bone disease, and deficiencies of fat-soluble vitamins [
         <a href="#rid79">
          79-81
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3718216890">
         <span class="h3">
          Vitamin deficiency
         </span>
         <span class="headingEndMark">
          —
         </span>
         BPD-DS is associated with a greater risk of vitamin D deficiency and secondary hyperparathyroidism because it induces more protein-calorie malnutrition than any other bariatric operation. In a five-year study of 1400 patients undergoing BPD-DS, vitamin D deficiency developed in up to 15 percent of patients at three years and secondary hyperparathyroidism in up to 68 percent of patients at five years [
         <a href="#rid82">
          82
         </a>
         ]. Consequently, the risk of fracture due to lower bone mineral density is also increased the greatest after BPD-DS. In one study, the fracture risk after BPD-DS was increased by 60 percent compared with nonsurgical controls with obesity [
         <a href="#rid41">
          41
         </a>
         ]. Due to the higher prevalence of metabolic bone disease, a higher dosage of supplementation and repletion of calcium and vitamin D is recommended after BPD-DS than after other bariatric operations [
         <a href="#rid83">
          83
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/587.html" rel="external">
          "Bariatric surgery: Postoperative nutritional management", section on 'Vitamin D'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/587.html" rel="external">
          "Bariatric surgery: Postoperative nutritional management", section on 'Calcium'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H40">
         <span class="h2">
          Adjustable gastric banding
         </span>
         <span class="headingEndMark">
          —
         </span>
         Adjustable gastric banding (AGB) is a purely restrictive procedure involving placement of an adjustable silicone device at the gastric cardia near the gastroesophageal junction, limiting the amount of food consumed. Restriction can be adjusted by injecting
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         into a subcutaneous port connected to the band  (
         <a class="graphic graphic_figure graphicRef60081" href="/z/d/graphic/60081.html" rel="external">
          figure 7
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/88536.html" rel="external">
          "Bariatric procedures for the management of severe obesity: Descriptions", section on 'Laparoscopic adjustable gastric banding'
         </a>
         .)
        </p>
        <p>
         AGB has the lowest mortality rate among all bariatric procedures (about 0.05 percent) [
         <a href="#rid84">
          84
         </a>
         ]. The early (&lt;30 days) complication rate is low (5 to 10 percent), but the late (&gt;30 days) complication rate is high (&gt;25 percent) [
         <a href="#rid84">
          84-89
         </a>
         ]. Almost 50 percent of patients will need surgical revision or removal of the band [
         <a href="#rid90">
          90
         </a>
         ]. Failed bands (due either to complications or inadequate weight loss) can generally be converted to other bariatric procedures such as RYGB, SG [
         <a href="#rid91">
          91
         </a>
         ], one-anastomosis gastric bypass [
         <a href="#rid92">
          92,93
         </a>
         ], or single-anastomosis duodenal switch [
         <a href="#rid94">
          94
         </a>
         ].
        </p>
        <p>
         Late complications of AGB include band erosion, band slippage or prolapse, port or tubing malfunction, leakage at the port site tubing or band, pouch or esophageal dilatation, esophagitis, and hiatal hernia [
         <a href="#rid95">
          95
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H43">
         <span class="h3">
          Band erosion
         </span>
         <span class="headingEndMark">
          —
         </span>
         Partial or complete band erosion through the gastric wall has been reported in 1 percent of AGB patients [
         <a href="#rid96">
          96
         </a>
         ], and it is thought to occur as a result of either gastric wall ischemia from an excessively tight band, mechanical trauma related to the band buckle, or thermal trauma from electrosurgical energy sources used during band placement [
         <a href="#rid97">
          97-99
         </a>
         ]  (
         <a class="graphic graphic_figure graphicRef76700" href="/z/d/graphic/76700.html" rel="external">
          figure 8
         </a>
         ). Band erosion is a late complication that occurs at a mean of 22 months after surgery [
         <a href="#rid97">
          97
         </a>
         ].
        </p>
        <p>
         Clinical signs of band erosion include port site infection, failure of weight loss, or nausea and vomiting [
         <a href="#rid100">
          100
         </a>
         ]. Epigastric pain and hematemesis can also signal erosion of the band into the left gastric artery [
         <a href="#rid101">
          101
         </a>
         ]. This can happen when the lap band erodes into the posterior part of the stomach near the cardioesophageal junction. This complication can be avoided by careful placement during the initial surgery, ensuring not to include the ascending branch of the left gastric artery during band placement.
        </p>
        <p>
         Band erosion can be diagnosed by endoscopy, and treatment involves removal of the band to avoid further complications. Band removal, along with repair of the gastric wall, is typically performed laparoscopically [
         <a href="#rid102">
          102
         </a>
         ]. An intraoperative leak test is performed, and a drain is placed. Revision to another bariatric procedure should be delayed for at least two to three months.
        </p>
        <p>
         Successful endoscopic removal has also been reported when the buckle of the band is visible endoscopically [
         <a href="#rid103">
          103,104
         </a>
         ]. However, endoscopic band removal is more technically challenging. (See
         <a class="medical medical_review" href="/z/d/html/2655.html" rel="external">
          "Gastrointestinal endoscopy in patients who have undergone bariatric surgery", section on 'Band erosion'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H44">
         <span class="h3">
          Band slippage and gastric prolapse
         </span>
         <span class="headingEndMark">
          —
         </span>
         In contemporary series, band slippage occurs at a rate of 5 to 8 percent [
         <a href="#rid96">
          96,105,106
         </a>
         ]. The modern pars flaccida approach with anterior band fixation by gastrogastric sutures is specifically designed to prevent band slippage [
         <a href="#rid107">
          107
         </a>
         ].
        </p>
        <p>
         Band slippage involves prolapse of part of the stomach through the band, with varying degrees of gastric obstruction. The stomach usually prolapses in one of three configurations [
         <a href="#rid108">
          108
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Anterior prolapse involves migration of the band cephalad, which creates an acute angle with the stomach pouch and esophagus, resulting in obstruction.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Posterior gastric prolapse occurs when the stomach migrates cephalad, displacing the band caudally and creating a new pouch  (
         <a class="graphic graphic_figure graphicRef81074" href="/z/d/graphic/81074.html" rel="external">
          figure 9
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Symmetric prolapse, also referred to as symmetric pouch dilation, differs from anterior and posterior prolapse, which are asymmetric prolapses.
        </p>
        <p>
        </p>
        <p>
         Gastric prolapse is characterized by food intolerance, epigastric pain, and acid reflux [
         <a href="#rid106">
          106
         </a>
         ]. Diagnosis is confirmed with an abdominal plain film, CT, or an upper gastrointestinal series demonstrating either malposition of the band or dilatation and prolapse of the gastric pouch [
         <a href="#rid109">
          109,110
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14953.html" rel="external">
          "Imaging studies after bariatric surgery", section on 'Band slippage and gastric prolapse'
         </a>
         .)
        </p>
        <p>
         A slipped band can sometimes be repositioned by deflation, but often the band needs to be replaced or removed surgically if removing the fluid from the band does not reposition it. Although surgical correction of a slipped band is usually not an emergency, it should be performed in a timely manner to avoid further complications such as aspiration or gastric strangulation. Revision to another bariatric procedure should be delayed until the inflammation has subsided to avoid complications at the staple lines.
        </p>
        <p>
         In patients who present with acute onset epigastric pain, surgery is required urgently to exclude catastrophic complications such as gastric strangulation, ischemia, or volvulus [
         <a href="#rid111">
          111,112
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/140689.html" rel="external">
          "Bariatric operations: Late complications with acute presentations"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3442246442">
         <span class="h3">
          Esophageal dilatation or esophagitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Esophageal dilatation proximal to the band device has been reported in 6 percent of AGB patients [
         <a href="#rid113">
          113,114
         </a>
         ]. This so-called "pseudoachalasia syndrome" may develop when the band is excessively inflated or in the setting of excessive amounts of food intake. Pouch dilatation has also been associated with a history of binge eating behavior [
         <a href="#rid115">
          115
         </a>
         ].
        </p>
        <p>
         Patients often present with food and saliva intolerance, reflux, and epigastric discomfort. The diagnosis can be confirmed with an upper gastrointestinal series. (See
         <a class="medical medical_review" href="/z/d/html/14953.html" rel="external">
          "Imaging studies after bariatric surgery", section on 'Esophageal dilation'
         </a>
         .)
        </p>
        <p>
         The initial treatment should be the removal of all the fluid from the band and behavioral diet modifications. This is usually successful in reversing esophageal dilatation [
         <a href="#rid116">
          116
         </a>
         ]. The band should not be reinflated for at least eight weeks. However, persistent dilatation may require replacement of the band in a new location on the stomach or conversion to a RYGB.
        </p>
        <p>
         Esophagitis and reflux are infrequent early complications following AGB [
         <a href="#rid117">
          117
         </a>
         ]. Deflation of the band and acid suppression therapy are the mainstays of treatment. However, if intractable to medical therapy, band removal or conversion to other procedures such as RYGB may be necessary. (See
         <a class="medical medical_review" href="/z/d/html/2258.html" rel="external">
          "Medical management of gastroesophageal reflux disease in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1199440331">
         <span class="h3">
          Hiatal hernia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hiatal hernia is often a preexisting but unrecognized condition in patients undergoing bariatric surgery [
         <a href="#rid118">
          118
         </a>
         ]. This can lead to ongoing intractable reflux necessitating reoperation or band removal  (
         <a class="graphic graphic_diagnosticimage graphicRef82446" href="/z/d/graphic/82446.html" rel="external">
          image 2
         </a>
         ). Thus, a simple crural repair can be performed at the initial operation to avoid these complications [
         <a href="#rid119">
          119
         </a>
         ]. A retrospective review of 1298 patients who underwent AGB alone and 520 patients who underwent AGB with concurrent hiatal hernia repair showed that the rate of reoperation was significantly reduced in patients who had hiatal repair at the time of AGB as compared with those who had AGB alone (1.7 versus 5.6 percent, respectively) [
         <a href="#rid118">
          118
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14953.html" rel="external">
          "Imaging studies after bariatric surgery", section on 'Hiatus hernia'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2259.html" rel="external">
          "Hiatus hernia", section on 'Management'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1117339311">
         <span class="h3">
          Port malfunction or infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Port malfunction results if the tubing disconnects, subcutaneous port flips, or leakage within the system occurs. Such problems lead to inability to titrate the instilled volume of
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         in the system. The reported incidence of port and tubing malfunction ranges from 0.4 to 7 percent [
         <a href="#rid120">
          120,121
         </a>
         ]. These problems usually become evident as an inability to access the port and maintain band volume, or with the development of weight gain. These complications require surgical repair or exchange of the hardware to attain band adjustability. (See
         <a class="medical medical_review" href="/z/d/html/14953.html" rel="external">
          "Imaging studies after bariatric surgery", section on 'Tubing migration or disconnection'
         </a>
         .)
        </p>
        <p>
         Port infection has been reported in 0.3 to 9 percent of AGB patients [
         <a href="#rid87">
          87,122,123
         </a>
         ]. Because the port is a foreign body, port infection is treated with surgical removal, especially in association with band erosion. If an isolated port infection is found, the infected port is removed, and a new port is reimplanted once the infection clears.
        </p>
        <p class="headingAnchor" id="H49">
         <span class="h2">
          Vertical banded gastroplasty
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vertical banded gastroplasty (VBG), also known as "stomach stapling," is a purely restrictive procedure involving the creation of a small proximal gastric pouch lined by a vertical staple line and a tight prosthetic mesh  (
         <a class="graphic graphic_figure graphicRef57137" href="/z/d/graphic/57137.html" rel="external">
          figure 10
         </a>
         ) [
         <a href="#rid124">
          124
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/88536.html" rel="external">
          "Bariatric procedures for the management of severe obesity: Descriptions", section on 'Vertical banded gastroplasty'
         </a>
         .)
        </p>
        <p>
         The VBG has been largely supplanted by other bariatric procedures and is no longer performed, but patients who underwent VBG still present to bariatric surgeons today with complications including staple line disruption, stomal stenosis, band erosion, GERD, nausea/vomiting, marginal ulcers, and weight regain [
         <a href="#rid125">
          125
         </a>
         ]. In long-term studies, up to 40 percent of patients require reoperation for complications (eg, vomiting), and up to 30 percent require another bariatric procedure [
         <a href="#rid126">
          126-128
         </a>
         ]. VBG is more commonly converted to an RYGB or a BPD [
         <a href="#rid129">
          129
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H50">
         <span class="h3">
          Staple line disruption
         </span>
         <span class="headingEndMark">
          —
         </span>
         Disruption of the staple line results in a fistula to the fundus, which can lead to decreased restriction in the VBG [
         <a href="#rid130">
          130,131
         </a>
         ]. This complication can occur in 27 to 31 percent of the patients and can be as high as 48 percent if assessed on routine postoperative endoscopy [
         <a href="#rid132">
          132
         </a>
         ]. Staple line disruption typically leads to weight regain due to increased food consumption since patients can eat around their restriction without feeling full.
        </p>
        <p class="headingAnchor" id="H51">
         <span class="h3">
          Obstruction
         </span>
         <span class="headingEndMark">
          —
         </span>
         Stomal stenosis occurs in approximately 20 to 33 percent and can occur due to fibrosis in the stomach or by the band itself [
         <a href="#rid127">
          127,133
         </a>
         ]. The resulting obstruction leads to food intolerance, reflux, and often weight regain due to dietary shifts to calorically dense liquids and softer foods. Staple line dehiscence, esophageal dilatation, and a fistula between the VBG pouch and occluded stomach have also been reported [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
         Stomal stenosis following VBG can initially be managed nonoperatively by endoscopic dilation, with surgery reserved for failures. However, dilation may be unsuccessful due to the rigid nature of the prosthetic band. A success rate of 68 percent for endoscopic dilation of stomal stenosis was described in one series [
         <a href="#rid134">
          134
         </a>
         ]. Symptomatic relief following endoscopic dilation is often short lived, and surgical revision may be necessary when symptoms persist. Dense scarring also presents a significant operative risk when revision is required.
        </p>
        <p class="headingAnchor" id="H52">
         <span class="h3">
          Erosion of mesh band
         </span>
         <span class="headingEndMark">
          —
         </span>
         Band erosion is a frequent late complication of VBG occurring with an incidence of 1 to 7 percent and usually occurs one to three years after the surgery [
         <a href="#rid132">
          132,135
         </a>
         ]. Patients generally present with abdominal pain and vomiting. Surgical removal is indicated if erosion is visualized by endoscopy.
        </p>
        <p class="headingAnchor" id="H53">
         <span class="h3">
          Reflux
         </span>
         <span class="headingEndMark">
          —
         </span>
         Gastroesophageal reflux after VBG presents with classic symptoms such as burning pain, heartburn, aspiration, and cough. It typically occurs as a late complication as a result of stomal stenosis and pouch dilatation [
         <a href="#rid136">
          136
         </a>
         ]. GERD unresponsive to antireflux medical therapy often requires reversal of the VBG or conversion to RYGB. In a review of 25 patients undergoing a revision of a VBG for symptomatic reflux, esophagitis was present in 58 percent of patients and Barrett esophagus in 28 percent [
         <a href="#rid136">
          136
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2258.html" rel="external">
          "Medical management of gastroesophageal reflux disease in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H54">
         <span class="h3">
          Vomiting
         </span>
         <span class="headingEndMark">
          —
         </span>
         Recurrent vomiting occurs in approximately 8 to 21 percent of patients following VBG [
         <a href="#rid126">
          126
         </a>
         ]. The etiology may be multifactorial, including maladaptive dietary patterns (such as eating too quickly or not chewing properly) as well as functional problems such as stomal stenosis, pouch dilatation, staple line disruption, or GERD. These patients will often become sweet eaters to ingest calories in a form that does not cause vomiting.
        </p>
        <p>
         Not all patients with recurrent vomiting require an operative revision. Initial treatment should consist of dietary modification (ie, proper chewing, eating at a slower pace, and avoidance of problem foods that give recurrent vomiting) and radiologic and/or endoscopic evaluations for structural problems. Operative revision is required if the vomiting persists and leads to malnutrition and/or dehydration [
         <a href="#rid127">
          127
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H56">
         <span class="h2">
          Jejunoileal bypass
         </span>
         <span class="headingEndMark">
          —
         </span>
         Jejunoileal bypass (JIB) is a purely malabsorptive procedure that was popular in the 1960s and 1970s. The procedure produces significant weight loss by creating a surgical short bowel syndrome  (
         <a class="graphic graphic_figure graphicRef53171" href="/z/d/graphic/53171.html" rel="external">
          figure 11
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/88536.html" rel="external">
          "Bariatric procedures for the management of severe obesity: Descriptions", section on 'Jejunoileal bypass'
         </a>
         .)
        </p>
        <p>
         JIB is no longer used today because of a 50 percent morbidity rate and a 10 percent mortality rate [
         <a href="#rid137">
          137
         </a>
         ]. Over half of the patients who underwent JIB developed diarrhea and electrolyte imbalances [
         <a href="#rid138">
          138
         </a>
         ], and these problems could persist more than five years after surgery. Patients who previously underwent JIB should be followed carefully for signs of complications, including arthritis, protein malnutrition, vitamin deficiencies, cirrhosis, nephrolithiasis with oxalate stones, and renal failure [
         <a href="#rid139">
          139-142
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H58">
         <span class="h3">
          Renal failure
         </span>
         <span class="headingEndMark">
          —
         </span>
         Increased absorption of calcium oxalate leads to deposition in the renal parenchyma, which can lead to postobstruction nephropathy and renal failure [
         <a href="#rid143">
          143,144
         </a>
         ]. Conversion to a RYGB or reversal should be considered in patients with metabolic complications [
         <a href="#rid145">
          145,146
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H59">
         <span class="h3">
          Cirrhosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hepatic abnormalities that may lead to cirrhosis can occur in up to 40 percent of patients and may persist or progress despite reversal in more than one-third of patients [
         <a href="#rid147">
          147,148
         </a>
         ]. Progressive liver injury appears histologically as increasing steatosis, lobular lymphocytic inflammation, pericellular fibrosis, Mallory bodies, and deranged architecture, all features resembling those seen in alcoholic liver disease [
         <a href="#rid149">
          149-151
         </a>
         ].
        </p>
        <p>
         Some patients have progressed to decompensated cirrhosis requiring liver transplantation [
         <a href="#rid152">
          152,153
         </a>
         ]. If not already performed, reversal of the jejunoileal bypass at the time of transplant should be considered. Reversal prior to transplant may not be feasible because of the risk of precipitating hepatic decompensation in patients with advanced liver disease. Patients who do not undergo reversal at the time of transplant should be monitored closely, with reversal performed in those who develop progressive liver injury [
         <a href="#rid149">
          149,152,153
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2346581318">
         <span class="h1">
          REOPERATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Evaluations of longer-term safety of bariatric operations most often center on rates of reoperation and reinterventions. In contemporary series, the reoperation rate following bariatric surgery generally ranges from 5 to 22.1 percent [
         <a href="#rid4">
          4,154
         </a>
         ]. Roux-en-Y gastric bypass has higher rates of reoperations compared with sleeve gastrectomy in cohort studies [
         <a href="#rid155">
          155,156
         </a>
         ] but not randomized trials [
         <a href="#rid157">
          157,158
         </a>
         ]. The incidence of reoperations may also change with the length of follow-up [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H103314781">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/112687.html" rel="external">
          "Society guideline links: Bariatric surgery"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H60">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Common complications
         </strong>
         – Late (&gt;30 days), nonacute complications that can occur after all bariatric procedures include cholelithiasis, ventral incisional hernias, and change in bowel habits. (See
         <a class="local">
          'Complications common to all procedures'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Roux-en-Y gastric bypass
         </strong>
         – Late (&gt;30 days), nonacute complications of Roux-en-Y gastric (RYGB) bypass include dumping syndrome (early and late), metabolic and nutritional derangements, gastrogastric fistulas (GGF), short bowel syndrome, and candy cane Roux syndrome. For patients with persistent pain, bleeding, or stenosis from a GGF, we suggest surgical revision rather than other treatments (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). (See
         <a class="local">
          'Roux-en-Y gastric bypass'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sleeve gastrectomy
         </strong>
         – Late (&gt;30 days), nonacute complications of sleeve gastrectomy (SG) include gastroesophageal reflux disease and Barrett esophagus. (See
         <a class="local">
          'Sleeve gastrectomy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Biliopancreatic diversion
         </strong>
         – Late (&gt;30 days), nonacute complications of biliopancreatic diversion (BPD) with or without duodenal switch include significant protein-calorie malnutrition, anemia, metabolic bone disease, and deficiencies of fat-soluble vitamins (eg, vitamin D) and vitamin B12. (See
         <a class="local">
          'Biliopancreatic diversion and duodenal switch'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Adjustable gastric banding
         </strong>
         – Late (&gt;30 days), nonacute complications of adjustable gastric banding include band erosion, band slippage leading to gastric prolapse, port malfunction or infection, esophageal dilatation or esophagitis, and hiatal hernia. About half of these patients require revision surgery. (See
         <a class="local">
          'Adjustable gastric banding'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Vertical banded gastroplasty
         </strong>
         – Although no longer performed, vertical banded gastroplasty complications include staple line disruption, stomal stenosis, band erosion, reflux, nausea/vomiting, marginal ulcers, and weight regain. About 40 percent of patients require revision surgery. (See
         <a class="local">
          'Vertical banded gastroplasty'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Jejunoileal bypass
         </strong>
         – Jejunoileal bypass is no longer performed because of a high morbidity and mortality rate. However, patients who underwent this procedure can present years later with significant complications, including arthritis, protein malnutrition, vitamin deficiencies, cirrhosis, nephrolithiasis with oxalate stones, and renal failure. (See
         <a class="local">
          'Jejunoileal bypass'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Reoperations
         </strong>
         – In contemporary series, the reoperation rate following bariatric surgery generally ranges from 5 to 22 percent. RYGB is associated with higher rates of reoperations compared with SG in cohort studies but not randomized trials. (See
         <a class="local">
          'Reoperations'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Clapp B, Ponce J, DeMaria E, et al. American Society for Metabolic and Bariatric Surgery 2020 estimate of metabolic and bariatric procedures performed in the United States. Surg Obes Relat Dis 2022; 18:1134.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Encinosa WE, Bernard DM, Du D, Steiner CA. Recent improvements in bariatric surgery outcomes. Med Care 2009; 47:531.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Longitudinal Assessment of Bariatric Surgery (LABS) Consortium, Flum DR, Belle SH, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009; 361:445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and Risks of Bariatric Surgery in Adults: A Review. JAMA 2020; 324:879.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guzmán HM, Sepúlveda M, Rosso N, et al. Incidence and Risk Factors for Cholelithiasis After Bariatric Surgery. Obes Surg 2019; 29:2110.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li VK, Pulido N, Fajnwaks P, et al. Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy. Surg Endosc 2009; 23:1640.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amorim-Cruz F, Santos-Sousa H, Ribeiro M, et al. Risk and Prophylactic Management of Gallstone Disease in Bariatric Surgery: a Systematic Review and A Bayesian meta-analysis. J Gastrointest Surg 2023; 27:433.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xia C, Wang M, Lv H, et al. The Safety and Necessity of Concomitant Cholecystectomy During Bariatric Surgery in Patients with Obesity: a Systematic Review and Meta-analysis. Obes Surg 2021; 31:5418.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fearon NM, Kearns EC, Kennedy CA, et al. The impact of ursodeoxycholic acid on gallstone disease after bariatric surgery: a meta-analysis of randomized control trials. Surg Obes Relat Dis 2022; 18:77.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mulliri A, Menahem B, Alves A, Dupont B. Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials. J Gastroenterol 2022; 57:529.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hossain I, Brodie J, O'Brien E, et al. Ursodeoxycholic acid for prevention of gallstone disease after laparoscopic sleeve gastrectomy: an Atlantic Canada perspective. Surg Endosc 2023; 37:5236.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Connell M, Sun WYL, Mocanu V, et al. Management of choledocholithiasis after Roux-en-Y gastric bypass: a systematic review and pooled proportion meta-analysis. Surg Endosc 2022; 36:6868.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Basta MN, Mirzabeigi MN, Shubinets V, et al. Predicting incisional hernia after bariatric surgery: a risk stratification model based upon 2161 operations. Surg Obes Relat Dis 2016; 12:1466.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vilallonga R, Beisani M, Sanchez-Cordero S, et al. Abdominal Wall Hernia and Metabolic Bariatric Surgery. J Laparoendosc Adv Surg Tech A 2020; 30:891.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Menzo EL, Hinojosa M, Carbonell A, et al. American Society for Metabolic and Bariatric Surgery and American Hernia Society consensus guideline on bariatric surgery and hernia surgery. Surg Obes Relat Dis 2018; 14:1221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spaniolas K, Kasten KR, Mozer AB, et al. Synchronous Ventral Hernia Repair in Patients Undergoing Bariatric Surgery. Obes Surg 2015; 25:1864.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moszkowicz D, Jacota M, Nkam L, et al. Ventral Hernia Repair and Obesity: Results from a Nationwide Register Study in France According to the Timeframes of Hernia Repair and Bariatric Surgery. Obes Surg 2021; 31:5251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Potoczna N, Harfmann S, Steffen R, et al. Bowel habits after bariatric surgery. Obes Surg 2008; 18:1287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Borbély YM, Osterwalder A, Kröll D, et al. Diarrhea after bariatric procedures: Diagnosis and therapy. World J Gastroenterol 2017; 23:4689.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ostruszka P, Vávra P, Tulinský L, Ihnát P. Changes in bowel habits after laparoscopic sleeve gastrectomy. Wideochir Inne Tech Maloinwazyjne 2020; 15:469.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elias K, Bekhali Z, Hedberg J, et al. Changes in bowel habits and patient-scored symptoms after Roux-en-Y gastric bypass and biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis 2018; 14:144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Campbell M, Conaty EA, Attaar M, et al. Patient-reported bowel and bladder function is not adversely impacted by bariatric surgery. Surg Endosc 2022; 36:6896.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scarpellini E, Arts J, Karamanolis G, et al. International consensus on the diagnosis and management of dumping syndrome. Nat Rev Endocrinol 2020; 16:448.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nielsen JB, Pedersen AM, Gribsholt SB, et al. Prevalence, severity, and predictors of symptoms of dumping and hypoglycemia after Roux-en-Y gastric bypass. Surg Obes Relat Dis 2016; 12:1562.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Beek AP, Emous M, Laville M, Tack J. Dumping syndrome after esophageal, gastric or bariatric surgery: pathophysiology, diagnosis, and management. Obes Rev 2017; 18:68.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tack J, Deloose E. Complications of bariatric surgery: dumping syndrome, reflux and vitamin deficiencies. Best Pract Res Clin Gastroenterol 2014; 28:741.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ukleja A. Dumping syndrome: pathophysiology and treatment. Nutr Clin Pract 2005; 20:517.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eisenberg D, Azagury DE, Ghiassi S, et al. ASMBS Position Statement on Postprandial Hyperinsulinemic Hypoglycemia after Bariatric Surgery. Surg Obes Relat Dis 2017; 13:371.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Upala S, Jaruvongvanich V, Sanguankeo A. Risk of nephrolithiasis, hyperoxaluria, and calcium oxalate supersaturation increased after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis. Surg Obes Relat Dis 2016; 12:1513.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Agrawal V. Oxalate mediated renal complications after Roux-en-Y gastric bypass: weighing the risks versus benefits. Surg Obes Relat Dis 2016; 12:1521.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nasr SH, D'Agati VD, Said SM, et al. Oxalate nephropathy complicating Roux-en-Y Gastric Bypass: an underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol 2008; 3:1676.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kamel TH, Maroz N. Medical Management of Advanced Oxalate Nephropathy Secondary to Gastric Bypass Surgery. Am J Med Sci 2021; 361:517.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Agrawal V, Wilfong JB, Rich CE, Gibson PC. Reversal of Gastric Bypass Resolves Hyperoxaluria and Improves Oxalate Nephropathy Secondary to Roux-en-Y Gastric Bypass. Case Rep Nephrol Dial 2016; 6:114.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fish E, Beverstein G, Olson D, et al. Vitamin D status of morbidly obese bariatric surgery patients. J Surg Res 2010; 164:198.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carlin AM, Rao DS, Meslemani AM, et al. Prevalence of vitamin D depletion among morbidly obese patients seeking gastric bypass surgery. Surg Obes Relat Dis 2006; 2:98.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim J, Nimeri A, Khorgami Z, et al. Metabolic bone changes after bariatric surgery: 2020 update, American Society for Metabolic and Bariatric Surgery Clinical Issues Committee position statement. Surg Obes Relat Dis 2021; 17:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim J, Brethauer S, ASMBS Clinical Issues Committee, American Society for Metabolic and Bariatric Surgery Clinical Issues Committee, Position Statement. Metabolic bone changes after bariatric surgery. Surg Obes Relat Dis 2015; 11:406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schafer AL, Weaver CM, Black DM, et al. Intestinal Calcium Absorption Decreases Dramatically After Gastric Bypass Surgery Despite Optimization of Vitamin D Status. J Bone Miner Res 2015; 30:1377.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hage MP, El-Hajj Fuleihan G. Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass. Osteoporos Int 2014; 25:423.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang Q, Chen Y, Li J, et al. A meta-analysis of the effects of bariatric surgery on fracture risk. Obes Rev 2018; 19:728.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rousseau C, Jean S, Gamache P, et al. Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study. BMJ 2016; 354:i3794.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nakamura KM, Haglind EG, Clowes JA, et al. Fracture risk following bariatric surgery: a population-based study. Osteoporos Int 2014; 25:151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Axelsson KF, Werling M, Eliasson B, et al. Fracture Risk After Gastric Bypass Surgery: A Retrospective Cohort Study. J Bone Miner Res 2018; 33:2122.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ahlin S, Peltonen M, Sjöholm K, et al. Fracture risk after three bariatric surgery procedures in Swedish obese subjects: up to 26 years follow-up of a controlled intervention study. J Intern Med 2020; 287:546.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sayadi Shahraki M, Mahmoudieh M, Kalidari B, et al. Bone Health after Bariatric Surgery: Consequences, Prevention, and Treatment. Adv Biomed Res 2022; 11:92.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wei JH, Lee WJ, Chong K, et al. High Incidence of Secondary Hyperparathyroidism in Bariatric Patients: Comparing Different Procedures. Obes Surg 2018; 28:798.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cai Z, Zhang Q, Jiang Y, et al. Bariatric surgery and secondary hyperparathyroidism: a meta-analysis. Surg Obes Relat Dis 2023; 19:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vinegrad N, Staretz-Chacham O, Barski L, Bartal C. Nonhepatic hyperammonemic encephalopathy complications following bariatric surgery: a case report and review of the literature. J Med Case Rep 2021; 15:385.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salcedo JD, Goldstein JS, Quinonez JM, Mosetti MA. Nonfatal Hyperammonemic Encephalopathy as a Late Complication of Roux-en-Y Gastric Bypass. Case Rep Gastrointest Med 2019; 2019:9031087.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kromas ML, Mousa OY, John S. Hyperammonemia-induced encephalopathy: A rare devastating complication of bariatric surgery. World J Hepatol 2015; 7:1007.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allan PJ, Stevens P, Abraham A, et al. Outcome of intestinal failure after bariatric surgery: experience from a national UK referral centre. Eur J Clin Nutr 2016; 70:772.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McBride CL, Petersen A, Sudan D, Thompson J. Short bowel syndrome following bariatric surgical procedures. Am J Surg 2006; 192:828.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Gossum A, Pironi L, Chambrier C, et al. Home parenteral nutrition (HPN) in patients with post-bariatric surgery complications. Clin Nutr 2017; 36:1345.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chousleb E, Patel S, Szomstein S, Rosenthal R. Reasons and operative outcomes after reversal of gastric bypass and jejunoileal bypass. Obes Surg 2012; 22:1611.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abdal Raheem S, Deen OJ, Corrigan ML, et al. Bariatric surgery complications leading to small bowel transplant: a report of 4 cases. JPEN J Parenter Enteral Nutr 2014; 38:513.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carrodeguas L, Szomstein S, Soto F, et al. Management of gastrogastric fistulas after divided Roux-en-Y gastric bypass surgery for morbid obesity: analysis of 1,292 consecutive patients and review of literature. Surg Obes Relat Dis 2005; 1:467.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Capella JF, Capella RF. Gastro-gastric fistulas and marginal ulcers in gastric bypass procedures for weight reduction. Obes Surg 1999; 9:22.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chahine E, Kassir R, Dirani M, et al. Surgical Management of Gastrogastric Fistula After Roux-en-Y Gastric Bypass: 10-Year Experience. Obes Surg 2018; 28:939.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pauli EM, Beshir H, Mathew A. Gastrogastric fistulae following gastric bypass surgery-clinical recognition and treatment. Curr Gastroenterol Rep 2014; 16:405.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsai C, Kessler U, Steffen R, et al. Endoscopic Closure of Gastro-gastric Fistula After Gastric Bypass: a Technically Feasible Procedure but Associated with Low Success Rate. Obes Surg 2019; 29:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Corcelles R, Jamal MH, Daigle CR, et al. Surgical management of gastrogastric fistula. Surg Obes Relat Dis 2015; 11:1227.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nymo S, Lundanes J, Aukan M, et al. Diet and physical activity are associated with suboptimal weight loss and weight regain 10-15 years after Roux-en-Y gastric bypass: A cross-sectional study. Obes Res Clin Pract 2022; 16:163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nymo S, Børresen Skjølsvold O, Aukan M, et al. Suboptimal Weight Loss 13 Years After Roux-en-Y Gastric Bypass: Is Hedonic Hunger, Eating Behaviour and Food Reward to Blame? Obes Surg 2022; 32:2263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hourneaux De Moura DT, Thompson CC. Endoscopic management of weight regain following Roux-en-Y gastric bypass. Expert Rev Endocrinol Metab 2019; 14:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hakiza L, Sartoretto A, Burgmann K, et al. Transoral Outlet Reduction (TORe) for the Treatment of Weight Regain and Dumping Syndrome after Roux-en-Y Gastric Bypass. Medicina (Kaunas) 2023; 59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aryaie AH, Fayezizadeh M, Wen Y, et al. "Candy cane syndrome:" an underappreciated cause of abdominal pain and nausea after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis 2017; 13:1501.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dallal RM, Cottam D. "Candy cane" Roux syndrome--a possible complication after gastric bypass surgery. Surg Obes Relat Dis 2007; 3:408.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kamocka A, McGlone ER, Pérez-Pevida B, et al. Candy cane revision after Roux-en-Y gastric bypass. Surg Endosc 2020; 34:2076.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gagner M, Deitel M, Kalberer TL, et al. The Second International Consensus Summit for Sleeve Gastrectomy, March 19-21, 2009. Surg Obes Relat Dis 2009; 5:476.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chhabra KR, Telem DA, Chao GF, et al. Comparative Safety of Sleeve Gastrectomy and Gastric Bypass: An Instrumental Variables Approach. Ann Surg 2022; 275:539.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kindel TL, Oleynikov D. The Improvement of Gastroesophageal Reflux Disease and Barrett's after Bariatric Surgery. Obes Surg 2016; 26:718.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yeung KTD, Penney N, Ashrafian L, et al. Does Sleeve Gastrectomy Expose the Distal Esophagus to Severe Reflux?: A Systematic Review and Meta-analysis. Ann Surg 2020; 271:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Qumseya BJ, Qumsiyeh Y, Ponniah SA, et al. Barrett's esophagus after sleeve gastrectomy: a systematic review and meta-analysis. Gastrointest Endosc 2021; 93:343.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silecchia G, Iossa A. GERD and Barrett's esophagus as indications for revisional surgery after sleeve gastrectomy: experience of a bariatric center of excellence IFSO-EC and narrative review. Expert Rev Endocrinol Metab 2021; 16:229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chiappetta S, Lainas P, Kassir R, et al. Gastroesophageal Reflux Disease as an Indication of Revisional Bariatric Surgery-Indication and Results-a Systematic Review and Metanalysis. Obes Surg 2022; 32:3156.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Skogar ML, Sundbom M. Duodenal Switch Is Superior to Gastric Bypass in Patients with Super Obesity when Evaluated with the Bariatric Analysis and Reporting Outcome System (BAROS). Obes Surg 2017; 27:2308.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hedberg J, Sundström J, Sundbom M. Duodenal switch versus Roux-en-Y gastric bypass for morbid obesity: systematic review and meta-analysis of weight results, diabetes resolution and early complications in single-centre comparisons. Obes Rev 2014; 15:555.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Skogar ML, Sundbom M. Early complications, long-term adverse events, and quality of life after duodenal switch and gastric bypass in a matched national cohort. Surg Obes Relat Dis 2020; 16:614.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Homan J, Betzel B, Aarts EO, et al. Vitamin and Mineral Deficiencies After Biliopancreatic Diversion and Biliopancreatic Diversion with Duodenal Switch--the Rule Rather than the Exception. Obes Surg 2015; 25:1626.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strain GW, Torghabeh MH, Gagner M, et al. The Impact of Biliopancreatic Diversion with Duodenal Switch (BPD/DS) Over 9 Years. Obes Surg 2017; 27:787.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sethi M, Chau E, Youn A, et al. Long-term outcomes after biliopancreatic diversion with and without duodenal switch: 2-, 5-, and 10-year data. Surg Obes Relat Dis 2016; 12:1697.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tardio V, Blais JP, Julien AS, et al. Serum Parathyroid Hormone and 25-Hydroxyvitamin D Concentrations Before and After Biliopancreatic Diversion. Obes Surg 2018; 28:1886.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Homan J, Schijns W, Aarts EO, et al. Treatment of Vitamin and Mineral Deficiencies After Biliopancreatic Diversion With or Without Duodenal Switch: a Major Challenge. Obes Surg 2018; 28:234.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carelli AM, Youn HA, Kurian MS, et al. Safety of the laparoscopic adjustable gastric band: 7-year data from a U.S. center of excellence. Surg Endosc 2010; 24:1819.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DeMaria EJ, Sugerman HJ, Meador JG, et al. High failure rate after laparoscopic adjustable silicone gastric banding for treatment of morbid obesity. Ann Surg 2001; 233:809.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Brien PE, Dixon JB. Lap-band: outcomes and results. J Laparoendosc Adv Surg Tech A 2003; 13:265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Angrisani L, Furbetta F, Doldi SB, et al. Lap Band adjustable gastric banding system: the Italian experience with 1863 patients operated on 6 years. Surg Endosc 2003; 17:409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jackson TD, Saleh F, Quereshy FA, et al. Short-term morbidity associated with removal and revision of the laparoscopic adjustable gastric band. Surg Obes Relat Dis 2014; 10:1110.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Himpens J, Cadière GB, Bazi M, et al. Long-term outcomes of laparoscopic adjustable gastric banding. Arch Surg 2011; 146:802.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khoraki J, Moraes MG, Neto APF, et al. Long-term outcomes of laparoscopic adjustable gastric banding. Am J Surg 2018; 215:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spaniolas K, Yang J, Zhu C, et al. Conversion of Adjustable Gastric Banding to Stapling Bariatric Procedures: Single- or Two-stage Approach. Ann Surg 2021; 273:542.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pujol-Rafols J, Uyanik O, Curbelo-Peña Y, et al. Adjustable Gastric Banding Conversion to One Anastomosis Gastric Bypass: Data Analysis of a Multicenter Database. J Gastrointest Surg 2022; 26:1147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Soprani A, Zulian V, Nedelcu M, Carandina S. One-stage conversion of laparoscopic adjustable gastric banding to laparoscopic 1-anastomosis gastric bypass: a single-center experience on 1,000 patients at 5 years of follow-up. Surg Obes Relat Dis 2022; 18:650.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pearlstein S, Sabrudin SA, Shayesteh A, et al. Outcomes After Laparoscopic Conversion of Failed Adjustable Gastric Banding (LAGB) to Laparoscopic Sleeve Gastrectomy (LSG) or Single Anastomosis Duodenal Switch (SADS). Obes Surg 2019; 29:1726.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Benson-Davies S, Rogers AM, Huberman W, et al. American Society of Metabolic and Bariatric Surgery consensus statement on laparoscopic adjustable gastric band management. Surg Obes Relat Dis 2022; 18:1120.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singhal R, Bryant C, Kitchen M, et al. Band slippage and erosion after laparoscopic gastric banding: a meta-analysis. Surg Endosc 2010; 24:2980.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suter M, Giusti V, Héraief E, Calmes JM. Band erosion after laparoscopic gastric banding: occurrence and results after conversion to Roux-en-Y gastric bypass. Obes Surg 2004; 14:381.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abu-Abeid S, Keidar A, Gavert N, et al. The clinical spectrum of band erosion following laparoscopic adjustable silicone gastric banding for morbid obesity. Surg Endosc 2003; 17:861.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown WA, Egberts KJ, Franke-Richard D, et al. Erosions after laparoscopic adjustable gastric banding: diagnosis and management. Ann Surg 2013; 257:1047.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cherian PT, Goussous G, Ashori F, Sigurdsson A. Band erosion after laparoscopic gastric banding: a retrospective analysis of 865 patients over 5 years. Surg Endosc 2010; 24:2031.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Png KS, Rao J, Lim KH, Chia KH. Lap-band causing left gastric artery erosion presenting with torrential hemorrhage. Obes Surg 2008; 18:1050.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Furbetta N, Gragnani F, Cervelli R, et al. Technical Details and Result of a Minimally Invasive Management of Gastric Band Erosions: a Series of 47 Patients. Obes Surg 2019; 29:3754.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manos T, Nedelcu A, Noel P, et al. Endoscopic Gastric Band Removal. J Clin Med 2023; 12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robinson TJ, Soriano C, Larsen M, et al. Endoscopic removal of eroded laparoscopic adjustable gastric bands: a preferred approach. Surg Obes Relat Dis 2020; 16:1030.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chevallier JM, Zinzindohoué F, Douard R, et al. Complications after laparoscopic adjustable gastric banding for morbid obesity: experience with 1,000 patients over 7 years. Obes Surg 2004; 14:407.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Szewczyk T, Janczak P, Jezierska N, Jurałowicz P. Slippage-a Significant Problem Following Gastric Banding-a Single Centre Experience. Obes Surg 2017; 27:2637.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Le Coq B, Frering V, Ghunaim M, et al. Impact of Surgical Technique on Long-term Complication Rate After Laparoscopic Adjustable Gastric Banding (LAGB): Results of a Single-blinded Randomized Controlled trial (ANOSEAN Study). Ann Surg 2016; 264:738.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sonavane SK, Menias CO, Kantawala KP, et al. Laparoscopic adjustable gastric banding: what radiologists need to know. Radiographics 2012; 32:1161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burt JR, Kocher MR, Snider L, et al. Computed Tomography Assessment of Gastric Band Slippage. Visc Med 2022; 38:288.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pieroni S, Sommer EA, Hito R, et al. The "O" sign, a simple and helpful tool in the diagnosis of laparoscopic adjustable gastric band slippage. AJR Am J Roentgenol 2010; 195:137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abu-Abeid A, Gosher N, Ovdat E, Eldar SM. Gastric Band Slippage with Associated Gastric Necrosis. Obes Surg 2023; 33:1625.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parys S, Werapitiya S. Acutely slipped gastric band with gastric necrosis and massive haemorrhage. J Surg Case Rep 2013; 2013.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Jong JR, Tiethof C, van Ramshorst B, et al. Esophageal dilation after laparoscopic adjustable gastric banding: a more systematic approach is needed. Surg Endosc 2009; 23:2802.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Furbetta N, Gragnani F, Flauti G, et al. Laparoscopic adjustable gastric banding on 3566 patients up to 20-year follow-up: Long-term results of a standardized technique. Surg Obes Relat Dis 2019; 15:409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poole N, Al Atar A, Bidlake L, et al. Pouch dilatation following laparoscopic adjustable gastric banding: psychobehavioral factors (can psychiatrists predict pouch dilatation?). Obes Surg 2004; 14:798.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khan A, Ren-Fielding C, Traube M. Potentially reversible pseudoachalasia after laparoscopic adjustable gastric banding. J Clin Gastroenterol 2011; 45:775.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rubenstein RB. Laparoscopic adjustable gastric banding at a U.S. center with up to 3-year follow-up. Obes Surg 2002; 12:380.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gulkarov I, Wetterau M, Ren CJ, Fielding GA. Hiatal hernia repair at the initial laparoscopic adjustable gastric band operation reduces the need for reoperation. Surg Endosc 2008; 22:1035.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ardestani A, Tavakkoli A. Hiatal hernia repair and gastroesophageal reflux disease in gastric banding patients: analysis of a national database. Surg Obes Relat Dis 2014; 10:438.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ren CJ, Horgan S, Ponce J. US experience with the LAP-BAND system. Am J Surg 2002; 184:46S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dargent J. Laparoscopic adjustable gastric banding: lessons from the first 500 patients in a single institution. Obes Surg 1999; 9:446.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keidar A, Carmon E, Szold A, Abu-Abeid S. Port complications following laparoscopic adjustable gastric banding for morbid obesity. Obes Surg 2005; 15:361.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cadière GB, Himpens J, Hainaux B, et al. Laparoscopic adjustable gastric banding. Semin Laparosc Surg 2002; 9:105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mason EE. Vertical banded gastroplasty for obesity. Arch Surg 1982; 117:701.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greilsamer T, Jacobi D, Krempf M, et al. Long-Term Complications of Open Mason's Vertical Banded Gastroplasty at a Single Tertiary Center and Literature Review. Am Surg 2019; 85:1386.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Balsiger BM, Poggio JL, Mai J, et al. Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity. J Gastrointest Surg 2000; 4:598.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Wezenbeek MR, Smulders JF, de Zoete JP, et al. Long-Term Results of Primary Vertical Banded Gastroplasty. Obes Surg 2015; 25:1425.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Froylich D, Abramovich TS, Fuchs S, et al. Long-Term (over 13 Years) Follow-Up of Vertical Band Gastroplasty. Obes Surg 2020; 30:1808.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mahajna A, Dubin D, Obeid M, et al. Short-Term (30-Day) Morbidity of Biliopancreatic Diversion Compared to Roux-en-Y Gastric Bypass as Revisional Procedures for Failed Vertical Banded Gastroplasty. Obes Surg 2023; 33:761.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sugerman HJ, Sugerman EL, DeMaria EJ, et al. Bariatric surgery for severely obese adolescents. J Gastrointest Surg 2003; 7:102.
          </a>
         </li>
         <li class="breakAll">
          Gonzalez RJ. Weight Loss Surgery: A multidisciplinary approach, Matrix Medical Communications, 2008.
         </li>
         <li>
          <a class="nounderline abstract_t">
           MacLean LD, Rhode BM, Sampalis J, Forse RA. Results of the surgical treatment of obesity. Am J Surg 1993; 165:155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suter M, Jayet C, Jayet A. Vertical banded gastroplasty: long-term results comparing three different techniques. Obes Surg 2000; 10:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sataloff DM, Lieber CP, Seinige UL. Strictures following gastric stapling for morbid obesity. Results of endoscopic dilatation. Am Surg 1990; 56:167.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moreno P, Alastrué A, Rull M, et al. Band erosion in patients who have undergone vertical banded gastroplasty: incidence and technical solutions. Arch Surg 1998; 133:189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Balsiger BM, Murr MM, Mai J, Sarr MG. Gastroesophageal reflux after intact vertical banded gastroplasty: correction by conversion to Roux-en-Y gastric bypass. J Gastrointest Surg 2000; 4:276.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Griffen WO Jr, Bivins BA, Bell RM. The decline and fall of the jejunoileal bypass. Surg Gynecol Obstet 1983; 157:301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spital A, Sterns RH. Metabolic acidosis following jejunoileal bypass. Am J Kidney Dis 1994; 23:135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hocking MP, Davis GL, Franzini DA, Woodward ER. Long-term consequences after jejunoileal bypass for morbid obesity. Dig Dis Sci 1998; 43:2493.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deitel M, Shahi B, Anand PK, et al. Long-term Outcome in a Series of Jejunoileal Bypass Patients. Obes Surg 1993; 3:247.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Våge V, Solhaug JH, Berstad A, et al. Jejunoileal bypass in the treatment of morbid obesity: a 25-year follow-up study of 36 patients. Obes Surg 2002; 12:312.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DeWind LT, Payne JH. Intestinal bypass surgery for morbid obesity: long-term results. JAMA 2014; 312:966.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mole DR, Tomson CR, Mortensen N, Winearls CG. Renal complications of jejuno-ileal bypass for obesity. QJM 2001; 94:69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taheri D, Sarmadi T, Shahidi S, et al. Oxalate nephropathy after Jejuno-Ileal bypass surgery. Saudi J Kidney Dis Transpl 2015; 26:1026.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anderson PE, Pilkington TR, Gazet JC. Reversal of jejunoileal bypass in patients with morbid obesity. Br J Surg 1994; 81:1015.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dhar NB, Grundfest S, Jones JS, Streem SB. Jejunoileal bypass reversal: effect on renal function, metabolic parameters and stone formation. J Urol 2005; 174:1844.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Styblo T, Martin S, Kaminski DL. The effects of reversal of jejunoileal bypass operations on hepatic triglyceride content and hepatic morphology. Surgery 1984; 96:632.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hocking MP, Duerson MC, O'Leary JP, Woodward ER. Jejunoileal bypass for morbid obesity. Late follow-up in 100 cases. N Engl J Med 1983; 308:995.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           D'Souza-Gburek SM, Batts KP, Nikias GA, et al. Liver transplantation for jejunoileal bypass-associated cirrhosis: allograft histology in the setting of an intact bypassed limb. Liver Transpl Surg 1997; 3:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kroyer JM, Talbert WM Jr. Morphologic liver changes in intestinal bypass patients. Am J Surg 1980; 139:855.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vyberg M, Ravn V, Andersen B. Pattern of progression in liver injury following jejunoileal bypass for morbid obesity. Liver 1987; 7:271.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Markowitz JS, Seu P, Goss JA, et al. Liver transplantation for decompensated cirrhosis after jejunoileal bypass: a strategy for management. Transplantation 1998; 65:570.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lowell JA, Shenoy S, Ghalib R, et al. Liver transplantation after jejunoileal bypass for morbid obesity. J Am Coll Surg 1997; 185:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Courcoulas A, Coley RY, Clark JM, et al. Interventions and Operations 5 Years After Bariatric Surgery in a Cohort From the US National Patient-Centered Clinical Research Network Bariatric Study. JAMA Surg 2020; 155:194.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li RA, Liu L, Arterburn D, et al. Five-year Longitudinal Cohort Study of Reinterventions After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass. Ann Surg 2021; 273:758.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewis KH, Arterburn DE, Callaway K, et al. Risk of Operative and Nonoperative Interventions Up to 4 Years After Roux-en-Y Gastric Bypass vs Vertical Sleeve Gastrectomy in a Nationwide US Commercial Insurance Claims Database. JAMA Netw Open 2019; 2:e1917603.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salminen P, Helmiö M, Ovaska J, et al. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial. JAMA 2018; 319:241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peterli R, Wölnerhanssen BK, Peters T, et al. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial. JAMA 2018; 319:255.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 585 Version 49.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35970741" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : American Society for Metabolic and Bariatric Surgery 2020 estimate of metabolic and bariatric procedures performed in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19318997" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Recent improvements in bariatric surgery outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19641201" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Perioperative safety in the longitudinal assessment of bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32870301" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Benefits and Risks of Bariatric Surgery in Adults: A Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31001756" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Incidence and Risk Factors for Cholelithiasis After Bariatric Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19057954" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36627465" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Risk and Prophylactic Management of Gallstone Disease in Bariatric Surgery: a Systematic Review and A Bayesian meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34564789" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : The Safety and Necessity of Concomitant Cholecystectomy During Bariatric Surgery in Patients with Obesity: a Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34772614" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : The impact of ursodeoxycholic acid on gallstone disease after bariatric surgery: a meta-analysis of randomized control trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35704084" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36952047" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Ursodeoxycholic acid for prevention of gallstone disease after laparoscopic sleeve gastrectomy: an Atlantic Canada perspective.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35041054" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Management of choledocholithiasis after Roux-en-Y gastric bypass: a systematic review and pooled proportion meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27425834" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Predicting incisional hernia after bariatric surgery: a risk stratification model based upon 2161 operations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32584652" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Abdominal Wall Hernia and Metabolic Bariatric Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30154033" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : American Society for Metabolic and Bariatric Surgery and American Hernia Society consensus guideline on bariatric surgery and hernia surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25702143" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Synchronous Ventral Hernia Repair in Patients Undergoing Bariatric Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34606046" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Ventral Hernia Repair and Obesity: Results from a Nationwide Register Study in France According to the Timeframes of Hernia Repair and Bariatric Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18327626" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Bowel habits after bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28765690" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Diarrhea after bariatric procedures: Diagnosis and therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32904607" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Changes in bowel habits after laparoscopic sleeve gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29108895" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Changes in bowel habits and patient-scored symptoms after Roux-en-Y gastric bypass and biliopancreatic diversion with duodenal switch.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35132450" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Patient-reported bowel and bladder function is not adversely impacted by bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32457534" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : International consensus on the diagnosis and management of dumping syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27425831" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Prevalence, severity, and predictors of symptoms of dumping and hypoglycemia after Roux-en-Y gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27749997" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Dumping syndrome after esophageal, gastric or bariatric surgery: pathophysiology, diagnosis, and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25194187" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Complications of bariatric surgery: dumping syndrome, reflux and vitamin deficiencies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16207692" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Dumping syndrome: pathophysiology and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28110984" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : ASMBS Position Statement on Postprandial Hyperinsulinemic Hypoglycemia after Bariatric Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27396545" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Risk of nephrolithiasis, hyperoxaluria, and calcium oxalate supersaturation increased after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27692909" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Oxalate mediated renal complications after Roux-en-Y gastric bypass: weighing the risks versus benefits.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18701613" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Oxalate nephropathy complicating Roux-en-Y Gastric Bypass: an underrecognized cause of irreversible renal failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33187632" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Medical Management of Advanced Oxalate Nephropathy Secondary to Gastric Bypass Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27781207" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Reversal of Gastric Bypass Resolves Hyperoxaluria and Improves Oxalate Nephropathy Secondary to Roux-en-Y Gastric Bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20850786" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Vitamin D status of morbidly obese bariatric surgery patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16925330" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Prevalence of vitamin D depletion among morbidly obese patients seeking gastric bypass surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33162343" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Metabolic bone changes after bariatric surgery: 2020 update, American Society for Metabolic and Bariatric Surgery Clinical Issues Committee position statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25487633" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Metabolic bone changes after bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25640580" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Intestinal Calcium Absorption Decreases Dramatically After Gastric Bypass Surgery Despite Optimization of Vitamin D Status.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24008401" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29334691" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : A meta-analysis of the effects of bariatric surgery on fracture risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27814663" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23912559" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Fracture risk following bariatric surgery: a population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30011091" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Fracture Risk After Gastric Bypass Surgery: A Retrospective Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32128923" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Fracture risk after three bariatric surgery procedures in Swedish obese subjects: up to 26 years follow-up of a controlled intervention study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36518856" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Bone Health after Bariatric Surgery: Consequences, Prevention, and Treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28921422" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : High Incidence of Secondary Hyperparathyroidism in Bariatric Patients: Comparing Different Procedures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36283949" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Bariatric surgery and secondary hyperparathyroidism: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34281619" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Nonhepatic hyperammonemic encephalopathy complications following bariatric surgery: a case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31355019" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Nonfatal Hyperammonemic Encephalopathy as a Late Complication of Roux-en-Y Gastric Bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25954483" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Hyperammonemia-induced encephalopathy: A rare devastating complication of bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27117932" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Outcome of intestinal failure after bariatric surgery: experience from a national UK referral centre.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17161102" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Short bowel syndrome following bariatric surgical procedures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27642058" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Home parenteral nutrition (HPN) in patients with post-bariatric surgery complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22810420" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Reasons and operative outcomes after reversal of gastric bypass and jejunoileal bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23636011" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Bariatric surgery complications leading to small bowel transplant: a report of 4 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16925272" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Management of gastrogastric fistulas after divided Roux-en-Y gastric bypass surgery for morbid obesity: analysis of 1,292 consecutive patients and review of literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10065576" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Gastro-gastric fistulas and marginal ulcers in gastric bypass procedures for weight reduction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28983751" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Surgical Management of Gastrogastric Fistula After Roux-en-Y Gastric Bypass: 10-Year Experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25113040" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Gastrogastric fistulae following gastric bypass surgery-clinical recognition and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30173285" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Endoscopic Closure of Gastro-gastric Fistula After Gastric Bypass: a Technically Feasible Procedure but Associated with Low Success Rate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26003896" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Surgical management of gastrogastric fistula.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35393266" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Diet and physical activity are associated with suboptimal weight loss and weight regain 10-15 years after Roux-en-Y gastric bypass: A cross-sectional study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35505168" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Suboptimal Weight Loss 13 Years After Roux-en-Y Gastric Bypass: Is Hedonic Hunger, Eating Behaviour and Food Reward to Blame?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30691326" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Endoscopic management of weight regain following Roux-en-Y gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36676749" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Transoral Outlet Reduction (TORe) for the Treatment of Weight Regain and Dumping Syndrome after Roux-en-Y Gastric Bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28552743" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : "Candy cane syndrome:" an underappreciated cause of abdominal pain and nausea after Roux-en-Y gastric bypass surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17533103" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : "Candy cane" Roux syndrome--a possible complication after gastric bypass surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31392513" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Candy cane revision after Roux-en-Y gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19632647" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : The Second International Consensus Summit for Sleeve Gastrectomy, March 19-21, 2009.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33201113" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Comparative Safety of Sleeve Gastrectomy and Gastric Bypass: An Instrumental Variables Approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26979967" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : The Improvement of Gastroesophageal Reflux Disease and Barrett's after Bariatric Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30921053" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Does Sleeve Gastrectomy Expose the Distal Esophagus to Severe Reflux?: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32798535" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Barrett's esophagus after sleeve gastrectomy: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34420434" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : GERD and Barrett's esophagus as indications for revisional surgery after sleeve gastrectomy: experience of a bariatric center of excellence IFSO-EC and narrative review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35776239" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Gastroesophageal Reflux Disease as an Indication of Revisional Bariatric Surgery-Indication and Results-a Systematic Review and Metanalysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28439748" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Duodenal Switch Is Superior to Gastric Bypass in Patients with Super Obesity when Evaluated with the Bariatric Analysis and Reporting Outcome System (BAROS).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24666623" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Duodenal switch versus Roux-en-Y gastric bypass for morbid obesity: systematic review and meta-analysis of weight results, diabetes resolution and early complications in single-centre comparisons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32156633" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Early complications, long-term adverse events, and quality of life after duodenal switch and gastric bypass in a matched national cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25595384" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Vitamin and Mineral Deficiencies After Biliopancreatic Diversion and Biliopancreatic Diversion with Duodenal Switch--the Rule Rather than the Exception.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27686233" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : The Impact of Biliopancreatic Diversion with Duodenal Switch (BPD/DS) Over 9 Years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27425842" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Long-term outcomes after biliopancreatic diversion with and without duodenal switch: 2-, 5-, and 10-year data.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29322299" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Serum Parathyroid Hormone and 25-Hydroxyvitamin D Concentrations Before and After Biliopancreatic Diversion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28861696" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Treatment of Vitamin and Mineral Deficiencies After Biliopancreatic Diversion With or Without Duodenal Switch: a Major Challenge.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20135179" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Safety of the laparoscopic adjustable gastric band: 7-year data from a U.S. center of excellence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11371739" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : High failure rate after laparoscopic adjustable silicone gastric banding for treatment of morbid obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14561255" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Lap-band: outcomes and results.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12457216" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Lap Band adjustable gastric banding system: the Italian experience with 1863 patients operated on 6 years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24913589" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Short-term morbidity associated with removal and revision of the laparoscopic adjustable gastric band.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21422330" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Long-term outcomes of laparoscopic adjustable gastric banding.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28693840" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Long-term outcomes of laparoscopic adjustable gastric banding.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30998539" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Conversion of Adjustable Gastric Banding to Stapling Bariatric Procedures: Single- or Two-stage Approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35230640" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Adjustable Gastric Banding Conversion to One Anastomosis Gastric Bypass: Data Analysis of a Multicenter Database.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35246392" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : One-stage conversion of laparoscopic adjustable gastric banding to laparoscopic 1-anastomosis gastric bypass: a single-center experience on 1,000 patients at 5 years of follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30767186" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Outcomes After Laparoscopic Conversion of Failed Adjustable Gastric Banding (LAGB) to Laparoscopic Sleeve Gastrectomy (LSG) or Single Anastomosis Duodenal Switch (SADS).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35981951" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : American Society of Metabolic and Bariatric Surgery consensus statement on laparoscopic adjustable gastric band management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20680349" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Band slippage and erosion after laparoscopic gastric banding: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15072660" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Band erosion after laparoscopic gastric banding: occurrence and results after conversion to Roux-en-Y gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12618932" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : The clinical spectrum of band erosion following laparoscopic adjustable silicone gastric banding for morbid obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23673685" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Erosions after laparoscopic adjustable gastric banding: diagnosis and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20177941" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Band erosion after laparoscopic gastric banding: a retrospective analysis of 865 patients over 5 years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18392902" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Lap-band causing left gastric artery erosion presenting with torrential hemorrhage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31520303" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Technical Details and Result of a Minimally Invasive Management of Gastric Band Erosions: a Series of 47 Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36675548" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Endoscopic Gastric Band Removal.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32540149" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Endoscopic removal of eroded laparoscopic adjustable gastric bands: a preferred approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15072664" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Complications after laparoscopic adjustable gastric banding for morbid obesity: experience with 1,000 patients over 7 years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28439749" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Slippage-a Significant Problem Following Gastric Banding-a Single Centre Experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27464616" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Impact of Surgical Technique on Long-term Complication Rate After Laparoscopic Adjustable Gastric Banding (LAGB): Results of a Single-blinded Randomized Controlled trial (ANOSEAN Study).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22787000" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Laparoscopic adjustable gastric banding: what radiologists need to know.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36160820" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Computed Tomography Assessment of Gastric Band Slippage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20566807" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : The "O" sign, a simple and helpful tool in the diagnosis of laparoscopic adjustable gastric band slippage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36920682" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Gastric Band Slippage with Associated Gastric Necrosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24964464" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Acutely slipped gastric band with gastric necrosis and massive haemorrhage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19466490" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Esophageal dilation after laparoscopic adjustable gastric banding: a more systematic approach is needed.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30704912" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Laparoscopic adjustable gastric banding on 3566 patients up to 20-year follow-up: Long-term results of a standardized technique.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15318985" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Pouch dilatation following laparoscopic adjustable gastric banding: psychobehavioral factors (can psychiatrists predict pouch dilatation?).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21778895" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Potentially reversible pseudoachalasia after laparoscopic adjustable gastric banding.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12082892" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Laparoscopic adjustable gastric banding at a U.S. center with up to 3-year follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18080712" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Hiatal hernia repair at the initial laparoscopic adjustable gastric band operation reduces the need for reoperation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24680760" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Hiatal hernia repair and gastroesophageal reflux disease in gastric banding patients: analysis of a national database.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12527351" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : US experience with the LAP-BAND system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10605901" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Laparoscopic adjustable gastric banding: lessons from the first 500 patients in a single institution.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15826470" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Port complications following laparoscopic adjustable gastric banding for morbid obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12152153" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Laparoscopic adjustable gastric banding.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7073493" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Vertical banded gastroplasty for obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31908223" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Long-Term Complications of Open Mason's Vertical Banded Gastroplasty at a Single Tertiary Center and Literature Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11307094" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25519773" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Long-Term Results of Primary Vertical Banded Gastroplasty.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32048151" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Long-Term (over 13 Years) Follow-Up of Vertical Band Gastroplasty.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36630053" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Short-Term (30-Day) Morbidity of Biliopancreatic Diversion Compared to Roux-en-Y Gastric Bypass as Revisional Procedures for Failed Vertical Banded Gastroplasty.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12559191" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Bariatric surgery for severely obese adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12559191" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Bariatric surgery for severely obese adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8418692" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Results of the surgical treatment of obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10715643" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : Vertical banded gastroplasty: long-term results comparing three different techniques.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2316938" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : Strictures following gastric stapling for morbid obesity. Results of endoscopic dilatation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9484733" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Band erosion in patients who have undergone vertical banded gastroplasty: incidence and technical solutions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10769090" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Gastroesophageal reflux after intact vertical banded gastroplasty: correction by conversion to Roux-en-Y gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6623319" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : The decline and fall of the jejunoileal bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8285189" id="rid137" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          138 : Metabolic acidosis following jejunoileal bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9824141" id="rid138" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          139 : Long-term consequences after jejunoileal bypass for morbid obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10757927" id="rid139" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          140 : Long-term Outcome in a Series of Jejunoileal Bypass Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12082879" id="rid140" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          141 : Jejunoileal bypass in the treatment of morbid obesity: a 25-year follow-up study of 36 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25182115" id="rid141" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          142 : Intestinal bypass surgery for morbid obesity: long-term results.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11181982" id="rid142" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          143 : Renal complications of jejuno-ileal bypass for obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26354586" id="rid143" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          144 : Oxalate nephropathy after Jejuno-Ileal bypass surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7710491" id="rid144" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          145 : Reversal of jejunoileal bypass in patients with morbid obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16217311" id="rid145" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          146 : Jejunoileal bypass reversal: effect on renal function, metabolic parameters and stone formation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6484807" id="rid146" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          147 : The effects of reversal of jejunoileal bypass operations on hepatic triglyceride content and hepatic morphology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6835318" id="rid147" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          148 : Jejunoileal bypass for morbid obesity. Late follow-up in 100 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9377754" id="rid148" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          149 : Liver transplantation for jejunoileal bypass-associated cirrhosis: allograft histology in the setting of an intact bypassed limb.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7386742" id="rid149" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          150 : Morphologic liver changes in intestinal bypass patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3695814" id="rid150" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          151 : Pattern of progression in liver injury following jejunoileal bypass for morbid obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9500634" id="rid151" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          152 : Liver transplantation for decompensated cirrhosis after jejunoileal bypass: a strategy for management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9249079" id="rid152" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          153 : Liver transplantation after jejunoileal bypass for morbid obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31940024" id="rid153" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          154 : Interventions and Operations 5 Years After Bariatric Surgery in a Cohort From the US National Patient-Centered Clinical Research Network Bariatric Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31188199" id="rid154" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          155 : Five-year Longitudinal Cohort Study of Reinterventions After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31851344" id="rid155" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          156 : Risk of Operative and Nonoperative Interventions Up to 4 Years After Roux-en-Y Gastric Bypass vs Vertical Sleeve Gastrectomy in a Nationwide US Commercial Insurance Claims Database.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29340676" id="rid156" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          157 : Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29340679" id="rid157" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          158 : Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
